chr7-24834709-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015550.4(OSBPL3):c.1523C>T(p.Ala508Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,612,534 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015550.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OSBPL3 | NM_015550.4 | c.1523C>T | p.Ala508Val | missense_variant | 15/23 | ENST00000313367.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OSBPL3 | ENST00000313367.7 | c.1523C>T | p.Ala508Val | missense_variant | 15/23 | 1 | NM_015550.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152216Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000168 AC: 42AN: 249270Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134692
GnomAD4 exome AF: 0.000165 AC: 241AN: 1460200Hom.: 0 Cov.: 32 AF XY: 0.000156 AC XY: 113AN XY: 726420
GnomAD4 genome AF: 0.000368 AC: 56AN: 152334Hom.: 1 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.1523C>T (p.A508V) alteration is located in exon 15 (coding exon 14) of the OSBPL3 gene. This alteration results from a C to T substitution at nucleotide position 1523, causing the alanine (A) at amino acid position 508 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at